El Salvador Launches AI-Powered Phase of "Dr. SV" App to Combat Chronic Disease Crisis

President Nayib Bukele launches Phase 2 of Dr. SV. The Google Cloud-powered app uses AI to monitor 3 million Salvadorans with diabetes, hypertension, and kidney issues.

By: AXL Media

Published: Apr 20, 2026, 10:23 AM EDT

Source: The Tico Times

AI-Driven Diagnostics and Patient Monitoring

The second phase of Dr. SV marks a significant shift from general teleconsultation to specialized chronic disease management. The application uses advanced algorithms to process digital questionnaires that identify early risk factors. For the 40% of hypertensive Salvadorans who are currently undiagnosed, the AI acts as a frontline screening tool, generating automatic laboratory orders and scheduling follow-ups. If a high-risk patient misses three consecutive appointments, the system triggers a mandatory human follow-up call, ensuring a closed-loop care cycle that was previously impossible in the traditional public health network.

Integration with Google Cloud and Gemini AI

The platform is a centerpiece of El Salvador’s seven-year, $500 million digital transformation agreement with Google. Google Cloud officials confirmed that the system utilizes the Gemini model to assist physicians with real-time diagnostic support. While the AI provides an initial assessment with a reported 93% accuracy rate in trials, President Bukele emphasized that human doctors remain the final decision-makers. The system is currently equipped to handle up to 30,000 appointments daily, significantly expanding the reach of the Hospital Nacional El Salvador.

Streamlined Treatment and Digital Records

A key feature of the Phase 2 rollout is the "Single Digital Health Record," which follows the patient across the entire public health network. Upon completing a virtual consultation, patients receive instant QR codes on their mobile devices. These codes are redeemable for free medications and lab tests at over 400 affiliated pharmacies and laboratories nationwide. This digital integration aims to eliminate the logistical hurdles and wait times that often lead to treatment non-compliance among kidney and diabetes patients.